,mitoparp,293,293 + high NAD,mitoparp + high NAD,mitoparp + low NAD,293 + low NAD,subsystem
1PPDCRc_MitoCore,1000.0,1000.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
1PPDCRc_NADPH_MitoCore,1000.0,1000.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
2HBO,1000.0,1000.0,0.0,0.0,0.0,0.0,Threonine and Methionine degradation
2HBt2,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
2OXOADOXm,1000.0,1000.0,0.030000000000000002,0.030000000000000002,0.01621276595744681,0.01621276595744681,Tryptophan / Lysine Metabolism 
34HPPOR,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tyrosine degradation
3HBCOAHLm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Valine degradation
3SALATAi,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation I
3SPYRSP,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation I
4ABUTtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,GABA shunt - transport
4aabutn_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Arginine degradation
5AOPtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Synthesis
AACTOORm_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycine degradation
AASAD3m,1000.0,1000.0,0.030000000000000002,0.030000000000000002,0.0043018867924528295,0.0043018867924528295,Lysine degradation (saccharopine pathway)
ABTArm,0.0,1000.0,1000.0,0.0,0.0,1000.0,GABA shunt
ABUTD,1000.0,1000.0,0.32200000000000006,0.0,0.0,0.32141719457013584,Ornithine degradation (cytosolic)
ACACT10m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Isoleucine degradation
ACACT1rm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA and ketone body metabolism / Ketogenesis
ACACt2,0.114,0.114,0.114,0.114,0.114,0.114,Boundary conditions - core
ACACt2mB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
ACADLC14_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
ACADLC16_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
ACALDtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Alcohol metabolism
ACCOAC,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
ACCOALm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Propanoate metabolism
ACITL,1000.0,0.0,0.0,1000.0,1000.0,0.0,Reductive carboxylation / Acetyl-CoA production for biosynthesis
ACITLm_MitoCore,1000.0,0.0,0.0,1000.0,1000.0,0.0,TCA cycle periphery
ACOAHi,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Acetate production
ACOATA,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
ACONT,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Reductive carboxylation
ACONTm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,TCA cycle
ACOT2_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Fatty acid elongation in mitochondria
ACSm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Alcohol metabolism
ACt2r,0.01,0.01,0.01,0.01,0.01,0.01,Boundary Conditions - Biomarkers
ADK1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cytosolic misc
ADK1m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,TCA cycle periphery
ADNK1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Methionine degradation
ADSL1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Purine Nucleotide Cycle
ADSS,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Purine Nucleotide Cycle
AGMTm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Arginine degradation
AHC,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Methionine degradation
AKGDm,1000.0,1000.0,7.452565217391304,7.327608695652174,3.9600268270120256,4.02755652173913,TCA cycle
AKGMALtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Malate aspartate shuttle
AKGt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
ALASm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Synthesis
ALATA_L,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cytosolic misc
ALAt2r,0.01,0.01,0.01,0.01,0.01,0.01,Boundary conditions - nonessential amino acids
ALCD2if,1000.0,1000.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALCD2yf,1000.0,1000.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2x,1000.0,1000.0,0.0,0.0,0.0,0.0,Alcohol metabolism
ALDD2xm,1000.0,1000.0,0.0,0.0,0.0,0.0,Alcohol metabolism
AMCOXO,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tryptophan Metabolism 
AMCOXO2_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tryptophan Metabolism 
AMPD1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Purine Nucleotide Cycle
AMPTASECG,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glutathione degradation
AOBUTDsm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycine degradation
APAT2rm,0.0,1000.0,1000.0,0.0,0.0,1000.0,Beta-alanine degradation
APRTO2m_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Arginine degradation
ARGDCm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Arginine degradation
ARGN,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Urea Cycle
ARGNm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Urea Cycle
ARGSL,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Urea Cycle
ARGSS,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Urea Cycle
ARGSUCt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
ARGtiDF,0.007,0.007,0.007,0.007,0.007,0.007,Boundary conditions - nonessential amino acids
ARGtmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
ASNS1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Asparagine synthesis
ASNtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
ASP1DC,0.0,0.0,0.0,0.0,0.0,0.0,Beta-alanine synthesis
ASPGLUmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Malate aspartate shuttle
ASPTA,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Malate aspartate shuttle
ASPTAm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Malate aspartate shuttle
ASPte,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary conditions - nonessential amino acids
ATPtmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
BALAtmr,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
BDHm,1000.0,1000.0,0.04800000000000001,0.04800000000000001,0.016800000000000002,0.016800000000000002,Ketone bodies - degradation
BHBt,0.048,0.048,0.048,0.048,0.048,0.048,Boundary conditions - core
BHBtmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
BILIRED,1000.0,1000.0,0.0,0.0,0.0,0.0,Haem Degradation
BILIRED2_MitoCore,1000.0,1000.0,0.0,0.0,0.0,0.0,Haem Degradation
BUTt2mB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
BUTt2r,0.006,0.006,0.006,0.006,0.006,0.006,Boundary conditions - alternative fuels
Biomass_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - core
Biomasst_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
C160CPT1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Carnitine shuttle
C160CPT2,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Carnitine shuttle
CBPSam,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Citrulline biosynthesis
CDSm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
CHLtmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
CHOLtu,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
CIII_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Electron transport chain
CII_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Electron transport chain
CITtamB,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
CITtbm,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
CIV_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Electron transport chain
CI_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Electron transport chain
CK,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Creatine ATP buffer
CKc,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Creatine ATP buffer
CLPN_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
CLS_hsm_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
CO2t,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary conditions - core
CO2tm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
COAtmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COAtmC_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
COt,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
CPPPGO,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Synthesis
CREATtmdiffir,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
CSm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,TCA cycle
CV_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Electron transport chain
CYANt,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
CYANtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
CYSTA,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation II
CYSTAm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation II
CYSTGL,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Methionine and Serine degradation
CYSTS,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Methionine and Serine degradation
CYStec,0.001,0.001,0.001,0.001,0.001,0.001,Boundary conditions - nonessential amino acids
CYTK1m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
DHFR,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
DHPR,1000.0,1000.0,0.012,0.012,0.011858823529411765,0.011858823529411765,Phenylalanine degradation
ECOAH12m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Valine degradation
ECOAH1m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
ECOAH9m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Isoleucine degradation
ENO,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis/gluconeogenesis
ETOHt,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
FA160ACPH,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
FACOAL160i,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Carnitine shuttle
FACOAL40im,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Butanoate metabolism
FBA,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis/gluconeogenesis
FBP,0.0,0.0,0.0,0.0,0.0,0.0,Gluconeogenesis
FCLTm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Synthesis
FE2t,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
FE2tm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
FKYNH,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tryptophan Metabolism 
FOLR2,0.0,0.0,0.0,0.0,0.0,0.0,Folate cytosolic
FOLt_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
FORt2mB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
FORt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
FTCD,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Folate cytosolic
FTHFDH,1000.0,1000.0,0.26566666666666666,0.687,0.685344578313253,0.2650265060240964,Folate cytosolic
FTHFDHm_MitoCore,1000.0,1000.0,0.0,0.0,0.0,0.0,Folate mitochondrial
FTHFL,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Folate cytosolic
FTHFLm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Folate mitochondrial
FUM,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cytosolic misc
FUMAC,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tyrosine degradation
FUMm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,TCA cycle
FUMt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
FUMtmB_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - uncharacterised
G3PD1,1000.0,1000.0,0.009999999999999998,0.009999999999999998,0.009718309859154929,0.009718309859154929,Glycerol phosphate shuttle
G5SADrm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Proline degradation/synthesis
G5SDym,1000.0,1000.0,22.137304202166813,9.135721354996736,1.801409844647244,4.365102237046978,Proline synthesis
G6PDH2r,0.0,1000.0,0.37699999999999795,0.0,0.0,0.3717513307984771,Pentose phosphate pathway
G6PPer,0.0,0.0,0.0,0.0,0.0,0.0,Gluconeogenesis
GAPD,1000.0,1000.0,1.81,1.8100000000000003,1.7147368421052633,1.7147368421052631,Glycolysis/gluconeogenesis
GCCam,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycine cleavage system (GCS)
GCCbim,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycine cleavage system (GCS)
GCCcm,1000.0,1000.0,0.13233333333333333,0.3430000000000001,0.18536595744680848,0.0715163120567376,Glycine cleavage system (GCS)
GHMT2r,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Serine and glycine biosynthesis
GHMT2rm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Serine and glycine biosynthesis
GLCt1r,0.9,0.9,0.9,0.9,0.9,0.9,Boundary conditions - core
GLNS,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glutamine synthesis
GLNtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
GLU5Km,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Proline synthesis
GLUCYS,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glutathione synthesis
GLUDC,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,GABA shunt
GLUDxi,1000.0,1000.0,0.322,0.3219999999999955,0.25348936170212405,0.25348936170212766,Glutamate degradation/synthesis - cytosolic
GLUDxm,1000.0,1000.0,0.322,0.3219999999999953,0.10021428571428428,0.1002142857142857,Glutamate degradation/synthesis
GLUDy,1000.0,1000.0,0.25133333333333274,0.3219999999999955,0.25348936170212405,0.19785815602836831,Glutamate degradation/synthesis - cytosolic
GLUDym,1000.0,1000.0,0.322,0.3219999999999954,0.10021428571428428,0.1002142857142857,Glutamate degradation/synthesis
GLUN_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glutamine degradation - cytosolic
GLUNm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glutamine degradation
GLUt2mB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
GLUt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - nonessential amino acids
GLYC3Ptm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
GLYCt,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary conditions - alternative fuels
GLYCtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
GLYK,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
GLYOXm,0.0,1000.0,1000.0,0.0,0.0,1000.0,Glycine degradation
GLYt2r,0.009,0.009,0.009,0.009,0.009,0.009,Boundary conditions - nonessential amino acids
GLYtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
GND,1000.0,1000.0,0.37699999999999273,0.0,0.0,0.34468571428570766,Pentose phosphate pathway
GPAMm_hsB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
GTHO,1000.0,1000.0,0.3219999999999995,0.322,0.3080756756757801,0.30807567567567135,ROS defense
GTHOm,1000.0,1000.0,0.1934975024975026,0.029350779655127487,0.022533824380388284,0.14855614707874798,ROS defense
GTHP,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,ROS defense
GTHPm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,ROS defense
GTHS,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glutathione synthesis
GluForTx,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Histidine degradation
H2Ot,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
H2Otm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
HACD1m,1000.0,1000.0,0.0,0.0,0.0,0.0,FA metabolism
HACD9m,1000.0,1000.0,0.004,0.004,0.003985967951494153,0.003985967951494153,Isoleucine degradation
HCO3t_MitoCore,1.71,1.71,1.71,1.71,1.71,1.71,Boundary conditions - core
HDCAtm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - core
HDCAtr,1.0,1.0,1.0,1.0,1.0,1.0,Boundary conditions - core
HEX1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis
HGNTOR,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tyrosine degradation
HIBDm,1000.0,1000.0,0.011,0.011,0.01096141186660718,0.01096141186660892,Valine degradation
HISD,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Histidine degradation
HIStiDF,0.01,0.01,0.01,0.01,0.01,0.01,Boundary conditions - essential amino acids
HKYNH,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tryptophan Metabolism 
HMBS,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Synthesis
HMGCOASim,0.0,0.0,0.0,0.0,0.0,0.0,Ketogenesis
HMGLm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Ketogenesis / Leucine degradation
HOXG,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Degradation
Hct_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
Hmt_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
HtmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
ICDHxm,1000.0,1000.0,81.90802554801715,9.141912732421059,7.922991034764919,70.9869554749482,TCA cycle
ICDHy,1000.0,1000.0,0.6540000000000001,4.041999999999967,3.8909802197801877,0.6295648351648353,Reductive carboxylation
ICDHyrm,1000.0,1000.0,7.968347826086954,7.781652173913039,6.183541056317475,6.331895185293257,TCA cycle
ICITt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
ILETAm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Isoleucine degradation
ILEt5m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
ILEtec,0.004,0.004,0.004,0.004,0.004,0.004,Boundary conditions - essential amino acids
IZPN,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Histidine degradation
KYN3OX,1000.0,1000.0,0.0,0.0,0.0,0.0,Tryptophan Metabolism 
LDH_Dm_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycine degradation
LDH_L,1000.0,1000.0,0.575,0.575,0.3718197879858657,0.3718197879858657,Glycolysis/gluconeogenesis
LEUTAm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Leucine degradation
LEUt5m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
LEUtec,0.016,0.016,0.016,0.016,0.016,0.016,Boundary conditions - essential amino acids
LGTHLm_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycine degradation
LPCOXc_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Lysine degradation (L-pipecolate pathway)
LYSOXc_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Lysine degradation (L-pipecolate pathway)
LYStiDF,0.03,0.03,0.03,0.03,0.03,0.03,Boundary conditions - essential amino acids
LYStmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
L_LACt2r,0.575,0.575,0.575,0.575,0.575,0.575,Boundary conditions - core
MACACI,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tyrosine degradation
MALSO3tm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
MALSO4tm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
MALTSULtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
MAL_Lte,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
MALtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
MCCCrm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Leucine degradation
MCLOR,1000.0,1000.0,0.0,0.0,0.0,0.0,Cysteine degradation II
MCOATA,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
MCPST,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation II
MCPSTm_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation II
MDH,1000.0,1000.0,2.0599999999999903,2.059999999999995,1.9115776397515483,1.9115776397515438,Malate aspartate shuttle
MDHm,1000.0,1000.0,9.590521739130436,9.61347826086956,6.267987826086953,6.253020173913044,TCA cycle
ME1m,1000.0,1000.0,1.9180000000000013,1.9180000000000066,0.3147182662538711,0.31471826625387017,TCA cycle periphery
ME2,1000.0,1000.0,0.7539999999999994,1.5193333333333308,1.5067981006083961,0.7477791363703808,Cytosolic misc
ME2m,1000.0,1000.0,1.9180000000000001,1.9180000000000004,1.8196228782287827,1.8196228782287824,TCA cycle periphery
MECR14C_MitoCore,1000.0,1000.0,16.450628726638286,9.141912732421062,2.38114936286316,4.284814924147646,Fatty acid elongation in mitochondria
MECR16C_MitoCore,1000.0,1000.0,16.450628726638286,9.141912732421055,2.3811493628631584,4.284814924147646,Fatty acid elongation in mitochondria
MERCPLACt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
METAT,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Methionine degradation
METAT2_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Methionine degradation
METtec,0.005,0.005,0.005,0.005,0.005,0.005,Boundary conditions - essential amino acids
MGCHrm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Leucine degradation
MMCDm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Propanoate synthesis
MMEm,1000.0,0.0,0.0,1000.0,1000.0,0.0,Propanoate metabolism
MMMm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Propanoate metabolism
MMSAD1m,1000.0,1000.0,0.011,0.011,0.0024161849710982956,0.002416184971098266,Propanoate metabolism
MMSAD3m,0.0,1000.0,0.0,0.0,0.0,0.0,Beta-alanine degradation
MMSAD3m2_MitoCore,0.0,1000.0,0.0,0.0,0.0,0.0,Beta-alanine degradation
MTHFC,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Folate cytosolic
MTHFCm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Folate mitochondrial
MTHFD,1000.0,1000.0,0.2556666666666666,0.677,0.6093000000000002,0.23010000000000003,Folate cytosolic
MTHFD2m,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
MTHFDm,0.0,0.0,0.0,0.0,0.0,0.0,Folate mitochondrial
MTPC14_MitoCore,1000.0,1000.0,1.0,1.0543913043478255,0.4044240619416316,0.38356164383561636,FA metabolism
MTPC16_MitoCore,1000.0,1000.0,1.0,1.054391304347826,0.4044240619416318,0.38356164383561636,FA metabolism
NABTNOm,1000.0,1000.0,0.1645,0.0,0.0,0.1625937768240343,Arginine degradation
NADHt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADHtm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NADtm_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
NDPK1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cytosolic misc
NDPK1m,0.0,1000.0,1000.0,0.0,0.0,1000.0,TCA cycle periphery
NDPK3m,0.0,1000.0,1000.0,0.0,0.0,1000.0,Cardiolipin synthesis
NH4t3r,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Biomarkers
NNT_MitoCore,0.0,1000.0,74.64694384710846,0.0,0.0,70.02306432945356,TCA cycle periphery
NOS1,1000.0,1000.0,0.3219999999999996,0.3219999999999956,0.32122409638553767,0.3212240963855418,NOS Signalling
NOS2,1000.0,1000.0,0.3219999999999996,0.3219999999999954,0.32122409638553767,0.3212240963855418,NOS Signalling
NOt,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
O2t,19.8,19.8,19.8,19.8,19.8,19.8,Boundary conditions - core
O2tm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
OAAt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
OCBTm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Citrulline biosynthesis
OCOAT1m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Ketone bodies - degradation
OF_ATP_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Objective Function - ATP 
OF_HEME_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Objective Function - Heme
OF_LIPID_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Objective Function - Lipid synthesis 
OF_PROTEIN_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Objective Function - Protein Synthesis
OIVD1m,1000.0,1000.0,0.016,0.016,0.0086468085106383,0.0086468085106383,Leucine degradation
OIVD2m,1000.0,1000.0,0.011000000000000001,0.011000000000000001,0.00594468085106383,0.00594468085106383,Valine degradation
OIVD3m,1000.0,1000.0,0.004,0.004,0.002161702127659575,0.002161702127659575,Isoleucine degradation
ORNDC,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Ornithine degradation (cytosolic)
ORNTArm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Ornithine degradation
ORNt3mB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
ORNt4mB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
P5CRm,1000.0,1000.0,16.45062872663828,9.141912732421062,2.9490041072326,5.306654427947833,Proline synthesis
P5CRxm,1000.0,1000.0,18.75541937524008,18.75689497647109,6.05061128273261,6.050135282335511,Proline synthesis
PCFLOPm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - lipids
PCHOLHSTDe,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Lipids
PCHOLPm_hs,0.0,1000.0,1000.0,0.0,0.0,1000.0,Cardiolipin synthesis
PCLAD,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tryptophan Metabolism 
PCREATtmdiffirB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
PCm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,TCA cycle periphery
PDHm,1000.0,1000.0,2.6305,2.662499999999996,1.4388829787234019,1.4215893617021276,TCA cycle
PEFLIPm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - lipids
PEPCK,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Gluconeogenesis
PEPCKm,0.0,1000.0,1000.0,0.0,0.0,1000.0,TCA cycle periphery
PEt,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Lipids
PFK,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis
PGCD,1000.0,1000.0,0.322,0.32199999999999546,0.31463999999999553,0.31464,Serine and glycine biosynthesis
PGI,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis/gluconeogenesis
PGK,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis/gluconeogenesis
PGL,0.0,1000.0,1000.0,0.0,0.0,1000.0,Pentose phosphate pathway
PGM,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis/gluconeogenesis
PGPPTm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
PGPP_hsm_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cardiolipin synthesis
PHEMEtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Synthesis
PHEtec,0.012,0.012,0.012,0.012,0.012,0.012,Boundary conditions - essential amino acids
PIt2mB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
PPA,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Carnitine shuttle
PPAm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Carnitine shuttle
PPAt,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
PPAtmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
PPCOACm,1000.0,0.0,0.0,1000.0,1000.0,0.0,Propanoate metabolism
PPD2CSPc_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Lysine degradation (L-pipecolate pathway)
PPPGOmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Synthesis
PROD2mB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Proline degradation
PROt2r,0.004,0.004,0.004,0.004,0.004,0.004,Boundary conditions - nonessential amino acids
PROtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
PSERT,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Serine and glycine biosynthesis
PSFLIPm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - lipids
PSP_L,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Serine and glycine biosynthesis
PSt3,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Lipids
PTRCAT1m_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Arginine degradation
PTRCOX1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Ornithine degradation (cytosolic)
PYK,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis/gluconeogenesis
PYRt2m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
R03103_MitoCore,1000.0,1000.0,0.030000000000000002,0.030000000000000002,0.0043018867924528295,0.0043018867924528295,Lysine degradation (saccharopine pathway)
RE1254C,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Lysine degradation (L-pipecolate pathway)
RE2649M,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Propanoate synthesis
RPE,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Pentose phosphate pathway
RPI,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Pentose phosphate pathway
SACCD3m,1000.0,1000.0,0.030000000000000002,0.030000000000000002,0.009029126213592231,0.009029126213592231,Lysine degradation (saccharopine pathway)
SO3t_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
SPODMm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,ROS defense
SUCCt2m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
SUCCt3m_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
SUCOAS1m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,TCA cycle
SUCOASm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,TCA cycle
SUMt_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
TALA,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Pentose phosphate pathway
TCYNTt,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
TCYNTtmB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
THRD_L,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Threonine degradation
TKT1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Pentose phosphate pathway
TKT2,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Pentose phosphate pathway
TPI,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis/gluconeogenesis
TRPO2,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tryptophan Metabolism 
TRPt,0.008,0.008,0.008,0.008,0.008,0.008,Boundary conditions - essential amino acids
TRPtm_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
TSULt_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
TYRTA,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tyrosine degradation
TYRTB_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tyrosine degradation
TYRt,0.011,0.011,0.011,0.011,0.011,0.011,Boundary conditions - nonessential amino acids
UPPDC1,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Haem Synthesis
URCN,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Histidine degradation
UREAt,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
UREAtm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
VALTAm,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Valine degradation
VALt5m,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
VALtec,0.011,0.011,0.011,0.011,0.011,0.011,Boundary conditions - essential amino acids
r0060,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Serine degradation
r0074,1000.0,1000.0,22.148304202166816,9.146721354996737,3.405950188768522,8.24732906475422,Proline / ornithine degradation
r0081,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,TCA cycle periphery
r0122,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycolysis
r0127,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Asparagine degradation
r0129,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glutathione degradation
r0178,1000.0,1000.0,7.452565217391283,0.0,0.0,3.193956521739121,GABA shunt
r0193,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation III
r0205,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Glycerol phosphate shuttle
r0226,1000.0,1000.0,0.0,0.0,0.0,0.0,Folate mitochondrial
r0287,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r0399,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Phenylalanine degradation
r0450,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Lysine degradation (saccharopine pathway)
r0464c_MitoCore,1000.0,1000.0,0.32199999999999984,0.0,0.0,0.3214171945701356,Ornithine degradation (cytosolic)
r0514,1000.0,1000.0,0.0,0.0,0.0,0.0,Folate mitochondrial
r0525,1000.0,1000.0,0.029999999999999995,0.029999999999999995,0.010097142857142857,0.010097142857142857,Lysine degradation (saccharopine pathway)
r0541,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tryptophan / Lysine Metabolism 
r0560,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Valine degradation
r0594,1000.0,1000.0,0.0,0.0,0.0,0.0,Lysine degradation (L-pipecolate pathway)
r0595B_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation II
r0595m_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Cysteine degradation II
r0603,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Isoleucine degradation
r0633,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0634,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r0638,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0645,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Tryptophan Metabolism 
r0655,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Leucine degradation
r0660,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r0678,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0681,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0682,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0691,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0692,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0693,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0694,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0695,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0696,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0697,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0701,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0702,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0712,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0713,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0722,1000.0,1000.0,1.0,1.0543913043478246,1.0506924868661367,0.9964919878735383,FA metabolism
r0724,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r0726,1000.0,1000.0,1.0,1.054391304347826,1.050692486866138,0.9964919878735383,FA metabolism
r0728,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r0730,1000.0,1000.0,1.0,1.0543913043478257,1.0506924868661378,0.9964919878735383,FA metabolism
r0731,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r0732,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r0733,1000.0,1000.0,1.0,1.0543913043478257,1.0506924868661378,0.9964919878735383,FA metabolism
r0734,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r0735,0.0,0.0,0.0,0.0,0.0,0.0,Fatty acid elongation in mitochondria
r0760,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0761,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0762,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0763,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0764,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0765,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0766,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0767,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0768,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0769,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0770,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0771,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0772,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA synthesis - cytosolic
r0773,1000.0,1000.0,0.0,0.0,0.0,0.0,FA synthesis - cytosolic
r0791,1000.0,1000.0,16.450628726638286,9.141912732421062,2.38114936286316,4.284814924147646,Fatty acid elongation in mitochondria
r0817,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Biomarkers
r0829,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
r0830,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
r0830B_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
r0838B_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
r0899,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Misc
r0913,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
r0917,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
r0917b_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Mitochondrial transporters - characterised
r0940,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
r0941,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transport - diffusion / artificial
r0942,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0942b_MitoCore,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - alternative fuels
r0962B_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
r1078,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
r1088,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r1154,1000.0,1000.0,0.017000000000000005,0.01699999999999312,0.009187234042553193,0.009187234042553193,Threonine and Methionine degradation
r1155,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Threonine degradation
r1423,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Boundary Conditions - Misc
r1427,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
r1434,0.001,0.001,0.001,0.001,0.001,0.001,Mitochondrial transporters - uncharacterised
r1435,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
r1436,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
r1437,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
r1440,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
r1446,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r1447,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r1448,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r1450,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r1451,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,FA metabolism
r1455,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - uncharacterised
r1512,0.0,0.0,0.0,0.0,0.0,0.0,Boundary Conditions - Biomarkers
r2398B_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
r2402B_MitoCore,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Mitochondrial transporters - characterised
r2435,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,Carnitine shuttle
r2525,0.0,0.0,0.0,0.0,0.0,0.0,Boundary conditions - nonessential amino acids
r2526,0.017,0.017,0.017,0.017,0.017,0.017,Boundary conditions - nonessential amino acids
r2532,0.01,0.01,0.01,0.01,0.01,0.01,Boundary conditions - nonessential amino acids
r2534,0.012,0.012,0.012,0.012,0.012,0.012,Boundary conditions - essential amino acids
